'Explant' technique predicts a tumor's responsiveness to breast cancer treatment
Cancer researchers at the University of Leicester have developed a technique that could predict how well some breast cancer ...
Mersana falls after early-stage trial data for lead cancer therapy
Cancer drug developer Mersana Therapeutics (NASDAQ:MRSN) hit a 52-week low on Friday after sharing early clinical results ...